PTX Capital — Full Portfolio
2 tracked investments · listed companies and verified rows first
Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins.
BiotechDeep TechHealthtechBaltimore, US
Benjamin Larman(Executive Officer, Director)inJoy M Nassif(Executive Officer, Director)in
BoardHerman Scholtz(Director)inCaroline Popper(Director)in
Board seatMatthew Hellauer· per SEC Form D · $7M raise · filed Aug 2025
Co-investorsIllumina VenturesTCP Venture Capital
Pair Team develops an AI-enabled care coordination platform that connects people with healthcare providers and programs to deliver proactive, personalized care.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Neil Batlivala(Founder)inCassie Choi(Founder)inCassandra Choi(Executive Officer, Director)
BoardJulian Eison(Director)in
Co-investorsCREATE HEALTH VENTURESHeadwater VenturesKapor CapitalNext VenturesNTT Venture CapitalNVP Capital+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.